Tarsus Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phas…

Biotechnology
US, Irvine [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of TARS's Analysis
CIK: 1819790 CUSIP: 87650L103 ISIN: US87650L1035 LEI: - UEI: -
Secondary Listings
TARS has no secondary listings inside our databases.